Fayez Sarofim & CO Gsk PLC Transaction History

Fayez Sarofim & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $42,618 - $48,383	-1,167 Reduced 14.35%	6,964 $277,000
Q1 2021 May 13, 2021	BUY	$34.27 - $40.01 $278,649 - $325,321	8,131 New	8,131 $290,000
Q1 2020 May 12, 2020	SELL	$32.47 - $48.83 $171,961 - $258,603	-5,296 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $12,726 - $14,619	303 Added 6.07%	5,296 $249,000
Q3 2019 Nov 13, 2019	BUY	$40.46 - $43.52 $202,016 - $217,295	4,993 New	4,993 $213,000
Q2 2019 Aug 09, 2019	SELL	$39.4 - $42.7 $204,131 - $221,228	-5,181 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $199,831 - $221,176	5,181 New	5,181 $217,000
Q4 2018 Feb 13, 2019	SELL	$37.8 - $42.69 $195,841 - $221,176	-5,181 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $205,944 - $221,176	5,181 New	5,181 $208,000
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $213,497 - $230,476	-5,390 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$36.18 - $40.15 $101,304 - $112,420	-2,800 Reduced 34.19%	5,390 $211,000
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $5,760 - $6,829	-163 Reduced 1.95%	8,190 $290,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $329,442 - $347,067	8,353	8,353 $339,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

Stay updated on Fayez Sarofim & CO with notifications on news.